Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 91 - 100 of 106 items for :

Clear All
Li Jing College of Physical Education, Chaohu University, Anhui Province, China

Search for other papers by Li Jing in
Google Scholar
PubMed Close
and
Wang Chengji College of Physical Education, Chaohu University, Anhui Province, China

Search for other papers by Wang Chengji in
Google Scholar
PubMed Close

BG levels of the exercise group decreased, but there was no significant change. After 120 min, compared with the model group, the BG of the exercise group decreased significantly. Figure 1 Oral glucose tolerance test (OGTT) curves of rats in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0012
Volume/Issue:
Volume 8: Issue 6
Open access
Xiaoxia Jia Center for Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China

Search for other papers by Xiaoxia Jia in
Google Scholar
PubMed Close
,
Yaxin An Center for Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China

Search for other papers by Yaxin An in
Google Scholar
PubMed Close
,
Yuechao Xu Center for Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China

Search for other papers by Yuechao Xu in
Google Scholar
PubMed Close
,
Yuxian Yang Center for Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China

Search for other papers by Yuxian Yang in
Google Scholar
PubMed Close
,
Chang Liu Center for Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China

Search for other papers by Chang Liu in
Google Scholar
PubMed Close
,
Dong Zhao Center for Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China

Search for other papers by Dong Zhao in
Google Scholar
PubMed Close
, and
Jing Ke Center for Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China

Search for other papers by Jing Ke in
Google Scholar
PubMed Close

defined according to 1999 World Health Organization Criteria ( 19 ), which include fasting blood glucose ≥ 7.0 mmol/L and/or 2-h blood glucose during a 75 g oral glucose tolerance test (OGTT) ≥ 11.1 mmol/L. Patients with endocrinological diseases, chronic

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0449
Volume/Issue:
Volume 10: Issue 10
Open access
Henrik Falhammar Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Search for other papers by Henrik Falhammar in
Google Scholar
PubMed Close
,
Magnus Kjellman Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Department of Breast and Endocrine Surgery, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Magnus Kjellman in
Google Scholar
PubMed Close
, and
Jan Calissendorff Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Search for other papers by Jan Calissendorff in
Google Scholar
PubMed Close

Dunn’s test: *Significant between all 3 groups; **Significant between incidentaloma presentation and Pheo suspicion groups. $ Defined as fasting plasma glucose 6–6.9 mmol/L and/or a 2 h OGTT value 7.8–11 and/or a HbA1c 42–47 mmol/mol. Table 2

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0321
Volume/Issue:
Volume 7: Issue 1
Open access
Aneta Gawlik Department of Pediatrics and Pediatric Endocrinology, School of Medicine in Katowice, Medical University of Silesia, Upper Silesia Children’s Care Health Centre, Katowice, Poland

Search for other papers by Aneta Gawlik in
Google Scholar
PubMed Close
,
Michael Shmoish Bioinformatics Knowledge Unit, Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering, Technion – Israel Institute of Technology, Haifa, Israel

Search for other papers by Michael Shmoish in
Google Scholar
PubMed Close
,
Michaela F Hartmann Steroid Research & Mass Spectrometry Unit, Division of Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany

Search for other papers by Michaela F Hartmann in
Google Scholar
PubMed Close
,
Stefan A Wudy Steroid Research & Mass Spectrometry Unit, Division of Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany

Search for other papers by Stefan A Wudy in
Google Scholar
PubMed Close
,
Zbigniew Olczak Department of Diagnostic Imaging, Upper Silesia Children’s Care Health Centre, Katowice, Poland

Search for other papers by Zbigniew Olczak in
Google Scholar
PubMed Close
,
Katarzyna Gruszczynska Department of Diagnostic Imaging, School of Medicine in Katowice, Medical University of Silesia, Upper Silesia Children’s Care Health Centre, Katowice, Poland

Search for other papers by Katarzyna Gruszczynska in
Google Scholar
PubMed Close
, and
Ze’ev Hochberg Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel

Search for other papers by Ze’ev Hochberg in
Google Scholar
PubMed Close

triglyceride (TG) levels were analyzed enzymatically (Beckman Coulter). GLU and INS levels were also measured in an oral glucose tolerance test (OGTT, 1.75 g/kg, max 75 g). Enzymatic test (hexokinase method) was used for the quantitative determination of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0536
Volume/Issue:
Volume 8: Issue 6
Open access
L Ahlkvist
Search for other papers by L Ahlkvist in
Google Scholar
PubMed Close
,
K Brown Department of Clinical Sciences, GlaxoSmithKline, Biomedical Center, C11, Lund University, SE 22184 Lund, Sweden

Search for other papers by K Brown in
Google Scholar
PubMed Close
, and
B Ahrén
Search for other papers by B Ahrén in
Google Scholar
PubMed Close

Krarup T . Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus . Diabetologia 2007 50 797 – 805 . ( doi:10.1007/s00125

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-12-0079
Volume/Issue:
Volume 2: Issue 2
Open access
Julia Otten Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Search for other papers by Julia Otten in
Google Scholar
PubMed Close
,
Andreas Stomby Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
Region Jönköping County, Jönköping, Sweden

Search for other papers by Andreas Stomby in
Google Scholar
PubMed Close
,
Maria Waling Department of Food, Nutrition and Culinary Science, Umeå University, Umeå, Sweden

Search for other papers by Maria Waling in
Google Scholar
PubMed Close
,
Elin Chorell Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Search for other papers by Elin Chorell in
Google Scholar
PubMed Close
,
Mats Ryberg Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Search for other papers by Mats Ryberg in
Google Scholar
PubMed Close
,
Michael Svensson Department of Community Medicine and Rehabilitation, Section for Sports Medicine, Umeå University, Umeå Sweden

Search for other papers by Michael Svensson in
Google Scholar
PubMed Close
,
Jens Juul Holst NNF Center for Basic Metabolic Research and Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jens Juul Holst in
Google Scholar
PubMed Close
, and
Tommy Olsson Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Search for other papers by Tommy Olsson in
Google Scholar
PubMed Close

. ( https://doi.org/10.1210/jcem-64-1-106 ) 18 Knop FK Vilsboll T Madsbad S Holst JJ Krarup T . Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0171
Volume/Issue:
Volume 10: Issue 9
Open access
Yuanyuan Li Department of Endocrinology, Inner Mongolia People’s Hospital, Hohhot, Inner Mongolia, China

Search for other papers by Yuanyuan Li in
Google Scholar
PubMed Close
,
Dongmei Li Department of Endocrinology, Inner Mongolia People’s Hospital, Hohhot, Inner Mongolia, China

Search for other papers by Dongmei Li in
Google Scholar
PubMed Close
, and
Xingbo Cheng Department of Endocrinology, The First Affiliated Hospital of Soochow University, Suzhou, China

Search for other papers by Xingbo Cheng in
Google Scholar
PubMed Close

monitored at the early stage of insulin resistance in GDM to explore the effects of the changes in susceptibility genes for diabetes and their expression. In our study, elevated glucose levels of oral glucose tolerance test (OGTT) were used as a diagnostic

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0227
Volume/Issue:
Volume 10: Issue 9
Open access
Johan Verhelst Department of Endocrinology, ZNA Middelheim Hospital, Antwerp, Belgium

Search for other papers by Johan Verhelst in
Google Scholar
PubMed Close
,
Anders F Mattsson Pfizer Endocrine Care, Pfizer Health AB, Sollentuna, Sweden

Search for other papers by Anders F Mattsson in
Google Scholar
PubMed Close
,
Cecilia Camacho-Hübner Pfizer Endocrine Care, Pfizer, Inc., New York, New York, USA

Search for other papers by Cecilia Camacho-Hübner in
Google Scholar
PubMed Close
,
Anton Luger Division of Endocrinology and Metabolism, Medical University and General Hospital, Vienna, Austria

Search for other papers by Anton Luger in
Google Scholar
PubMed Close
, and
Roger Abs Antwerp Centre for Endocrinology, Antwerp, Belgium

Search for other papers by Roger Abs in
Google Scholar
PubMed Close

>100 mg/dL (5.6 mmol/L) or type 2 diabetes (defined by a random or 2 h OGTT glucose ≥200 mg/dL (11.1 mmol/L); a HbA1c ≥6.4% or the use of anti-diabetic drugs ( 20 ). The MetS score, ranging between 0 and 5, corresponds to the sum of the abnormal MetS

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0096
Volume/Issue:
Volume 7: Issue 5
Open access
Anru Wang Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Department of Pediatrics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Anru Wang in
Google Scholar
PubMed Close
,
Xueqin Yan Department of Pediatrics, Boai Hospital of Zhongshan, Zhongshan, China

Search for other papers by Xueqin Yan in
Google Scholar
PubMed Close
,
Cai Zhang Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Cai Zhang in
Google Scholar
PubMed Close
,
Caiqi Du Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Caiqi Du in
Google Scholar
PubMed Close
,
Wenjun Long Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Wenjun Long in
Google Scholar
PubMed Close
,
Di Zhan Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Di Zhan in
Google Scholar
PubMed Close
, and
Xiaoping Luo Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Xiaoping Luo in
Google Scholar
PubMed Close

fasting glucose and insulin levels were increased in FGF1−/− mice fed with an HFD ( 22 ). Wang et al . reported that serum FGF1 significantly correlated with fasting glucose, 2-h post-OGTT glucose and HOMA-β ( 8 ). In addition, HbA1c were the independent

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0141
Volume/Issue:
Volume 7: Issue 8
Open access
Rongpeng Gong Medical College of Qinghai University, Xining, People’s Republic of China

Search for other papers by Rongpeng Gong in
Google Scholar
PubMed Close
,
Yuanyuan Liu Medical College of Qinghai University, Xining, People’s Republic of China

Search for other papers by Yuanyuan Liu in
Google Scholar
PubMed Close
,
Gang Luo Medical College of Qinghai University, Xining, People’s Republic of China

Search for other papers by Gang Luo in
Google Scholar
PubMed Close
,
Jiahui Yin College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China

Search for other papers by Jiahui Yin in
Google Scholar
PubMed Close
,
Zuomiao Xiao Department of Clinical Laboratory, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China

Search for other papers by Zuomiao Xiao in
Google Scholar
PubMed Close
, and
Tianyang Hu Precision Medicine Center, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

Search for other papers by Tianyang Hu in
Google Scholar
PubMed Close

blood glucose, or 2 h-OGTT test ≥ 11.0 mmol/L, was taking diabetes-related drugs. BMI was calculated based on height and weight, and its formula is BMI = weight/height-squared (kg/m 2 ). Laboratory data The collection of laboratory data was

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0066
Volume/Issue:
Volume 11: Issue 7
Open access